secwatch / observer
8-K filed June 9, 2023, 7:59 PM ET ticker HOOK CIK 0001760542
other material confidence high sentiment neutral materiality 0.05

Hookipa Pharma shareholders elect all three Class I director nominees and ratify PwC as auditor

HOOKIPA Pharma Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

HOOKIPA Pharma Inc. shareholders approved Election of Class I directors: Joern Aldag, Jan Van de Winkel and David Kaufman at the 2023-06-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-09
Exact text from the filing
The Company’s stockholders voted for the Class I directors as follows: Class I Director Nominee For Withhold Broker Non- Votes Joern Aldag 23,467,198 694,812 12,570,123 Jan Van de Winkel 22,299,220 1,862,790 12,570,123 David Kaufman 23,856,771 305,239 12,570,123
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

HOOKIPA Pharma Inc. shareholders approved Ratification of appointment of PwC Wirtschaftsprüfung GmbH as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-09
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Against Abstain 35,649,440 571,982 510,711
View on SEC.gov

Browse all shareholder votes →

HOOKIPA Pharma Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-070006
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.